Therapeutic Drug Monitoring of Ganciclovir: Where Are We?

Ganciclovir is the mainstay of therapy for the prophylaxis and treatment of Cytomegalovirus. However, therapy with this antiviral agent is hindered by side effects such as myelosuppression, which often leads to therapy cessation. Underdosing, as an attempt to prevent side effects, can lead to drug r...

Full description

Bibliographic Details

Published in:	Therapeutic drug monitoring Vol. 44; no. 1; p. 138
Main Authors:	Märtson, Anne-Grete, Edwina, Angela E, Kim, Hannah Yejin, Knoester, Marjolein, Touw, Daan J, Sturkenboom, Marieke G G, Alffenaar, Jan-Willem C
Format:	Journal Article
Language:	English
Published:	United States 01.02.2022
Subjects:	Antiviral Agents - adverse effects Cytomegalovirus Infections - drug therapy Drug Monitoring - methods Ganciclovir - therapeutic use Humans Valganciclovir - pharmacokinetics Valganciclovir - therapeutic use
ISSN:	1536-3694, 1536-3694
Online Access:	Get more information
Tags:	Add Tag No Tags, Be the first to tag this record!